Predicting optic atrophy in patients with anterior uveitis by computed tomography-based assessment of optic nerve diameter
DOI:
https://doi.org/10.31288/oftalmolzh202333841Keywords:
idiopathic anterior uveitis, optic neuritis and atrophy, computed tomography, assessment of optic nerve diameterAbstract
Background: An objective assessment of factors for ocular inflammation and its sequelae and diagnostic assessment of possible development of the sequelae in early phases of uveitis are essential for early and effective treatment of endogenous uveitis.
Purpose: To determine whether it is possible to predict optic atrophy in patients with anterior uveitis using computed tomography (CT)-based assessment of optic nerve diameter.
Material and Methods: Patients with anterior uveitis underwent a routine eye examination (ophthalmoscopy, biomicroscopy, intraocular pressure (IOP) measurement, and Humphrey perimetry). In addition, they underwent CT-based assessment of optic disc diameter at 3-5 mm from the entrance into the orbit in the affected eye and the contralateral healthy eye. Patients received treatment as per the protocol.
Results: The percentage difference in optic nerve diameter between patients with uveitis complicated by optic neuritis and those with uveitis only for affected eyes was large (33.1%) and statistically significant. At 3 months and 6 months after initiation of treatment, mean optic disc diameter in patients with optic neuritis decreased by 37.2% and 49.1%, respectively, compared to baseline values. At 6 months, a decrease in optic nerve diameter among optic neuritis patients was observed both in those who received treatment and in those who failed to receive treatment, but was less marked in the former patients. Particularly, from 3 months to 6 months, optic nerve diameter decreased by 17.3% in treated optic neuritis patients versus 23.5% in those who remained untreated.
Conclusion: CT-based data on the change in the optic nerve diameter at the entrance into the orbit in patients with optic neuritis is an objective characteristic of the presence and grade of atrophic process. Early identification of the potential for development of optic atrophy in individuals with optic neuritis will make it possible to treat them early and, consequently, to prevent or stabilize the process.
References
Панченко НВ, Самофалова МН, Гончарь ЕН, Литвищенко АВ, Фрянцева МВ. Истончение слоя перипапиллярных нервных волокон при увеите, осложненном воспалением зрительного нерва. Архів офтальмології України. 2016;4(1):50-3. https://doi.org/10.22141/2309-8147.4.1.2016.172896
Ковтун ОВ, Венгер ЛВ, Соколов ВМ. Патент № 144946, Україна МПК (2020.01) А61В 6/03. Спосіб прогнозування розвитку атрофії зорового нерва хворих на хронічний передній увеїт. Власник Одеський національний медичний університет. № заяв. u2020 02493; заявл. 11.09.2020; опубл. 27.04.2021. Реєстр нововведень № 15935/ЗУ/20.
Галінська ІВ, Салдан ЙР. Патент № 58918, Україна МПК (2002.11)A61F 9/00. Спосіб визначення ступеня атрофії зорового нерва. Власник Вінницький національний медичний університет ім. М. І. Пирогова. № заяв.U2002119304; заявл. 22.11.2002; опубл. 15.08.2003, Бюл. № 8.
Панченко МВ, Самофалова ММ, Гончарь ОМ, Фрянцева МВ. Патент. № 86135, Україна МПК (2013.01) A61F 9/00. Спосіб прогнозування розвитку часткової атрофії зорового нерва як наслідку запалення зорового нерва при увеїті. Власник Харківський національний медичний університет. № заяв.u 2013 09327; заявл. 25.07.2013; опубл. 10.12.2013, Бюл. № 23.
Пономарчук ВС, Дроженко ВС. Эффективность применения нового способа фосфенэлектростимуляции у больных с частичной атрофией зрительного нерва воспалительного генеза. Офтальмол. журн. 2001;1:39-42.
Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group (IUSG). International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul. Immunol. Inflamm. 2008;16:1-2. https://doi.org/10.1080/09273940801899822
Jabs DА, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshopuveitis. Am. J. Ophthalmol. 2005;140 (3):509-16. https://doi.org/10.1016/j.ajo.2005.03.057
Klistorner A, Chaganti J, Garricketal R. Magnetisation transferratioin optic neuritis is associated with axonal loss, but not with demyelination. Neuroimage. 2011;56 (1):21-6. https://doi.org/10.1016/j.neuroimage.2011.02.041
Kupersmith MJ, Anderson S, Kardon R. Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis. Multiple Sclerosis Journal. 2013;19(13):1743-48. https://doi.org/10.1177/1352458513485149
McNeil R. Grading of ocular inflammation in uveitis: an overviewneuritis. Eye news. 2016;22 (5):1-5. Available at: http://www.eyenews.uk.com].
Nussenblatt RВ, Whitcup SM. Uveitis: fundamentals and clinical practice. 3-d Ed., St. Louis:Mosby;2010. 480 p.
Petzold A, Plant GT. The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies. MultScler Int. 2012;2012:217802. https://doi.org/10.1155/2012/217802
Talla V, Yang C, Shaw G. et al. Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis. Invest. Ophthalmol. Vis. Sci. 2013;54:4440-50. https://doi.org/10.1167/iovs.13-11899
Zheng Z., Yuan R., Song M. et al. The toll-like receptor 4-mediated signaling pathway is activated following optic nerve injury in mice. Brain Res. 2012; 1489: 90-7. https://doi.org/10.1016/j.brainres.2012.10.014
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Venger L.V., Kovtun O.V., Savko V.V.
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
